Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Evaluation of the Influence of Three Newly Developed Bispyridinium Anti-nicotinic Compounds (MB408, MB442, MB444) on the Efficacy of Antidotal Treatment of Nerve Agent Poisoning in Mice

J. Kassa, CM. Timperley, M. Bird, RL. Williams, AC. Green, JEH. Tattersall,

. 2018 ; 122 (4) : 429-435. [pub] 20171205

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19001109

The influence of three newly developed bispyridinium antinicotinic compounds (the non-oximes MB408, MB442 and MB444) on the therapeutic efficacy of a standard antidotal treatment (atropine in combination with an oxime) of acute poisoning by the organophosphorus nerve agents tabun and soman was studied in mice. The therapeutic efficacy of atropine in combination with an oxime with or without one of the bispyridinium non-oximes was evaluated by determination of the LD50 values of the nerve agents and measurement of the survival time after supralethal poisoning. Addition of all the tested non-oximes increased significantly the therapeutic efficacy of atropine in combination with an oxime against tabun poisoning. They also positively influenced the number of surviving mice 6 hr after supralethal poisoning with tabun. However, they were only slightly effective for the treatment of soman poisoning. The benefit of the tested bispyridinium non-oximes was dose-dependent. To conclude, the addition of bispyridinium non-oximes to the standard antidotal treatment of acute poisoning with tabun was beneficial regardless of the chosen non-oxime, but only slightly beneficial in the case of soman poisoning.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001109
003      
CZ-PrNML
005      
20190110104437.0
007      
ta
008      
190107s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bcpt.12935 $2 doi
035    __
$a (PubMed)29117635
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kassa, Jiri $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic.
245    10
$a Evaluation of the Influence of Three Newly Developed Bispyridinium Anti-nicotinic Compounds (MB408, MB442, MB444) on the Efficacy of Antidotal Treatment of Nerve Agent Poisoning in Mice / $c J. Kassa, CM. Timperley, M. Bird, RL. Williams, AC. Green, JEH. Tattersall,
520    9_
$a The influence of three newly developed bispyridinium antinicotinic compounds (the non-oximes MB408, MB442 and MB444) on the therapeutic efficacy of a standard antidotal treatment (atropine in combination with an oxime) of acute poisoning by the organophosphorus nerve agents tabun and soman was studied in mice. The therapeutic efficacy of atropine in combination with an oxime with or without one of the bispyridinium non-oximes was evaluated by determination of the LD50 values of the nerve agents and measurement of the survival time after supralethal poisoning. Addition of all the tested non-oximes increased significantly the therapeutic efficacy of atropine in combination with an oxime against tabun poisoning. They also positively influenced the number of surviving mice 6 hr after supralethal poisoning with tabun. However, they were only slightly effective for the treatment of soman poisoning. The benefit of the tested bispyridinium non-oximes was dose-dependent. To conclude, the addition of bispyridinium non-oximes to the standard antidotal treatment of acute poisoning with tabun was beneficial regardless of the chosen non-oxime, but only slightly beneficial in the case of soman poisoning.
650    _2
$a zvířata $7 D000818
650    _2
$a antidota $x chemická syntéza $x farmakologie $x terapeutické užití $7 D000931
650    _2
$a atropin $x farmakologie $7 D001285
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a preklinické hodnocení léčiv $7 D004353
650    _2
$a synergismus léků $7 D004357
650    _2
$a kombinovaná farmakoterapie $7 D004359
650    _2
$a lidé $7 D006801
650    _2
$a LD50 $7 D007928
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a nervová bojová látka $x otrava $7 D000067397
650    _2
$a nikotinoví agonisté $x chemická syntéza $x farmakologie $7 D018722
650    _2
$a otrava organofosfáty $x farmakoterapie $x etiologie $7 D062025
650    _2
$a organofosfáty $x toxicita $7 D010755
650    _2
$a oximy $x farmakologie $7 D010091
650    _2
$a pyridinové sloučeniny $x chemická syntéza $x farmakologie $x terapeutické užití $7 D011726
650    _2
$a soman $x otrava $7 D012999
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Timperley, Christopher M $u Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, UK.
700    1_
$a Bird, Mike $u Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, UK.
700    1_
$a Williams, Rebecca L $u Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, UK.
700    1_
$a Green, A Christopher $u Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, UK.
700    1_
$a Tattersall, John E H $u Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory (Dstl), Porton Down, Salisbury, UK.
773    0_
$w MED00007578 $t Basic & clinical pharmacology & toxicology $x 1742-7843 $g Roč. 122, č. 4 (2018), s. 429-435
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29117635 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190110104641 $b ABA008
999    __
$a ok $b bmc $g 1365031 $s 1039232
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 122 $c 4 $d 429-435 $e 20171205 $i 1742-7843 $m Basic & clinical pharmacology & toxicology $n Basic Clin Pharmacol Toxicol $x MED00007578
LZP    __
$a Pubmed-20190107
Back

Find record

Citation metrics

Archiving options